ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
imback
|
222 |
102K |
0 |
12:18 |
12:18 |
ASX - By Stock
|
222
|
102K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
imback
|
222 |
102K |
5 |
09:13 |
09:13 |
ASX - By Stock
|
222
|
102K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
imback
|
222 |
102K |
4 |
27/12/24 |
27/12/24 |
ASX - By Stock
|
222
|
102K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
imback
|
222 |
102K |
6 |
27/12/24 |
27/12/24 |
ASX - By Stock
|
222
|
102K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
imback
|
222 |
102K |
6 |
27/12/24 |
27/12/24 |
ASX - By Stock
|
222
|
102K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
imback
|
222 |
102K |
11 |
26/12/24 |
26/12/24 |
ASX - By Stock
|
222
|
102K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
imback
|
222 |
102K |
6 |
26/12/24 |
26/12/24 |
ASX - By Stock
|
222
|
102K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
imback
|
222 |
102K |
44 |
26/12/24 |
26/12/24 |
ASX - By Stock
|
222
|
102K
|
44
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
imback
|
6.4K |
3.2M |
6 |
25/12/24 |
25/12/24 |
ASX - By Stock
|
6.4K
|
3.2M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
imback
|
15K |
4.9M |
4 |
24/12/24 |
24/12/24 |
ASX - By Stock
|
15K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Video channel'
|
|
imback
|
153 |
65K |
20 |
24/12/24 |
24/12/24 |
ASX - By Stock
|
153
|
65K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MSB Video channel'
|
|
imback
|
153 |
65K |
4 |
24/12/24 |
24/12/24 |
ASX - By Stock
|
153
|
65K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
imback
|
31 |
12K |
7 |
24/12/24 |
24/12/24 |
ASX - By Stock
|
31
|
12K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
imback
|
31 |
12K |
7 |
24/12/24 |
24/12/24 |
ASX - By Stock
|
31
|
12K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
imback
|
31 |
12K |
10 |
24/12/24 |
24/12/24 |
ASX - By Stock
|
31
|
12K
|
10
|
|
ASX - By Stock
|
PNV |
Re:
Ann: First $A10m sales month
|
|
imback
|
113 |
34K |
0 |
24/12/24 |
24/12/24 |
ASX - By Stock
|
113
|
34K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Video channel'
|
|
imback
|
153 |
65K |
3 |
23/12/24 |
23/12/24 |
ASX - By Stock
|
153
|
65K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Video channel'
|
|
imback
|
153 |
65K |
12 |
23/12/24 |
23/12/24 |
ASX - By Stock
|
153
|
65K
|
12
|
|
ASX - By Stock
|
PNV |
Re:
Ann: First $A10m sales month
|
|
imback
|
113 |
34K |
2 |
23/12/24 |
23/12/24 |
ASX - By Stock
|
113
|
34K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
imback
|
190 |
71K |
7 |
23/12/24 |
23/12/24 |
ASX - By Stock
|
190
|
71K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
imback
|
190 |
71K |
32 |
23/12/24 |
23/12/24 |
ASX - By Stock
|
190
|
71K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
imback
|
559 |
208K |
24 |
22/12/24 |
22/12/24 |
ASX - By Stock
|
559
|
208K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
imback
|
559 |
208K |
11 |
22/12/24 |
22/12/24 |
ASX - By Stock
|
559
|
208K
|
11
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
imback
|
190 |
71K |
7 |
22/12/24 |
22/12/24 |
ASX - By Stock
|
190
|
71K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
imback
|
190 |
71K |
2 |
22/12/24 |
22/12/24 |
ASX - By Stock
|
190
|
71K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
imback
|
190 |
71K |
6 |
21/12/24 |
21/12/24 |
ASX - By Stock
|
190
|
71K
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
imback
|
190 |
71K |
16 |
21/12/24 |
21/12/24 |
ASX - By Stock
|
190
|
71K
|
16
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
imback
|
190 |
71K |
8 |
21/12/24 |
21/12/24 |
ASX - By Stock
|
190
|
71K
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
imback
|
190 |
71K |
2 |
21/12/24 |
21/12/24 |
ASX - By Stock
|
190
|
71K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
imback
|
190 |
71K |
34 |
21/12/24 |
21/12/24 |
ASX - By Stock
|
190
|
71K
|
34
|
|
ASX - By Stock
|
CBA |
Re:
CBA TA update
|
|
imback
|
2.3K |
736K |
0 |
20/12/24 |
20/12/24 |
ASX - By Stock
|
2.3K
|
736K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
imback
|
1.4K |
638K |
10 |
20/12/24 |
20/12/24 |
ASX - By Stock
|
1.4K
|
638K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
imback
|
559 |
208K |
15 |
20/12/24 |
20/12/24 |
ASX - By Stock
|
559
|
208K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
imback
|
1.4K |
638K |
16 |
20/12/24 |
20/12/24 |
ASX - By Stock
|
1.4K
|
638K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
imback
|
1.4K |
638K |
12 |
20/12/24 |
20/12/24 |
ASX - By Stock
|
1.4K
|
638K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
FDA announcement re 1st MSC to treat SrGvHD
|
|
imback
|
63 |
22K |
3 |
20/12/24 |
20/12/24 |
ASX - By Stock
|
63
|
22K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
FDA announcement re 1st MSC to treat SrGvHD
|
|
imback
|
63 |
22K |
6 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
63
|
22K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
FDA announcement re 1st MSC to treat SrGvHD
|
|
imback
|
63 |
22K |
20 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
63
|
22K
|
20
|
|
ASX - By Stock
|
360 |
Re:
Ann: Statement of CDIs on issue - 360
|
|
imback
|
72 |
29K |
3 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
72
|
29K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
$3 we need a new target
|
|
imback
|
80 |
31K |
2 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
80
|
31K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
imback
|
559 |
208K |
14 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
559
|
208K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
$3 we need a new target
|
|
imback
|
80 |
31K |
16 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
80
|
31K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
imback
|
559 |
208K |
7 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
559
|
208K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
imback
|
559 |
208K |
10 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
559
|
208K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
imback
|
559 |
208K |
22 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
559
|
208K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
$3 we need a new target
|
|
imback
|
80 |
31K |
15 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
80
|
31K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
APPRoved
|
|
imback
|
193 |
47K |
20 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
193
|
47K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
imback
|
1.4K |
638K |
9 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
1.4K
|
638K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
imback
|
6.4K |
3.2M |
2 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
6.4K
|
3.2M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
APPRoved
|
|
imback
|
193 |
47K |
4 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
193
|
47K
|
4
|
|